Inventor
PARK MIYOUNG
KR14 patents
⚠️ This page may combine multiple inventors who share the name “PARK MIYOUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMOREPACIFIC CORP
11 patentsUS12178837B2Dec 31, 2024
Composition for skin-whitening or preventing or improving skin wrinkles comprising green tea extract which has modified amounts of ingredients
AMOREPACIFIC CORP0 citations59
US12059412B2Aug 13, 2024
Pharmaceutical composition containing (R)-N-[1-(3,5-difluoro-4-methanesulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethylpyridin-3-yl)-acrylamide and method for inhibiting crystal formation thereof
AMOREPACIFIC CORP0 citations59
US11896640B2Feb 13, 2024
Composition for skin-whitening or preventing or improving skin wrinkles comprising green tea extract which has modified amounts of ingredients
AMOREPACIFIC CORP0 citations59
US11878008B2Jan 23, 2024
Composition for preventing or treating atopic dermatitis
AMOREPACIFIC CORP0 citations57
US11382900B2Jul 12, 2022
Composition for preventing or treating sleep disorders
AMOREPACIFIC CORP0 citations57
US11938163B2Mar 26, 2024
Composition for improving respiratory health continuously exposed to particulate matter atmosphere
AMOREPACIFIC CORP0 citations56
US12364728B2Jul 22, 2025
Composition for reducing body fat comprising green tea extract containing gallocatechin gallate as an active ingredient and manufacturing method thereof
AMOREPACIFIC CORP0 citations51
US11998633B2Jun 4, 2024
Topical sol-gel composition for the treatment of dermatitis
AMOREPACIFIC CORP0 citations47
US10858315B2Dec 8, 2020
Method for preparing (R)-N-[4-(1-amino-ethyl)-2,6-difluoro-phenyl]-methanesulfonamide
AMOREPACIFIC CORP0 citations42
US10479763B2Nov 19, 2019
Chiral resolution method of N-[4-(1-aminoethyl)-phenyl]-sulfonamide derivatives
AMOREPACIFIC CORP0 citations36
US8013187B2Sep 6, 2011
2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-α
AMOREPACIFIC CORP0 citations36